Provenance du réseau au premier degré de Bowen Han
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong.
4
| Subsidiary | Investment Managers | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bowen Han via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Corporate Officer/Principal | |
| HUTCHMED (CHINA) LIMITED | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| HUATAI SECURITIES CO., LTD. | Investment Banks/Brokers | Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree | |
| Tsinghua University | College/University | Undergraduate Degree Undergraduate Degree | |
Allen & Overy (Hong Kong) Ltd.
 Allen & Overy (Hong Kong) Ltd. Miscellaneous Commercial ServicesCommercial Services 'Allen & Overy (Hong Kong) Ltd. is based in Hong Kong, Hong Kong. Part of Allen Overy Shearman Sterling LLP, Allen & Overy (Hong Kong) Ltd. is a Chinese company. The company was founded in 1988. | Miscellaneous Commercial Services | Private Equity Analyst | |
| McKinsey & Co. (Hong Kong) | Consultant / Advisor | ||
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Law School | College/University | Undergraduate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Graduate Degree | |
Hong Kong Asia Medical Holding Co. Ltd.
 Hong Kong Asia Medical Holding Co. Ltd. Medical/Nursing ServicesHealth Services Hong Kong Asia Medical Holding Co. Ltd. provides health care services. The company was founded in 1999 and is headquartered in Hong Kong. | Medical/Nursing Services | Director/Board Member | |
Biotheus, Inc.
 Biotheus, Inc. BiotechnologyHealth Technology Biotheus, Inc. is a biopharmaceutical company based in Zhuhai, China. The Chinese company aims to become a leading domestic biopharmaceutical company with a high-value product chain, strong innovation capabilities, and an experienced core team. It was founded in 2018 by Jun Wei Zeng, Xiao Lin Liu, and Zuo Yu Sun, with Xiao Lin Liu serving as the CEO. | Biotechnology | Director/Board Member | |
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Biotechnology | Director/Board Member | |
| Orbimed Advisors Private Equity/Hong Kong | Investment Managers | Private Equity Analyst | |
| Beijing Huatai Ruihe Healthcare Investment Fund LLP | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 7 |
| Hong Kong | 7 |
| Chine | 7 |
Sectorielle
| Health Technology | 6 |
| Finance | 5 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 4 |
| Private Equity Investor | 4 |
| Graduate Degree | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Le Fei Sun | 14 |
| Lefei Sun | 7 |
| Ivy Tang | 3 |
| Jacqueline Li | 1 |
